Chicago Equity Partners’s Edwards Lifesciences EW Stock Holding History

Chicago Equity Partners’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$759K	Buy	12,075 +3,990	+49%	+$288K	0.08%	329
2019 Q4	$629K	Hold	8,085	–	–	0.04%	588
2019 Q3	$593K	Buy	+8,085	New	+$568K	0.03%	641
2017 Q4	–	Sell	-8,460	Closed	-$308K	–	764
2017 Q3	$308K	Buy	+8,460	New	+$323K	0.01%	683
2016 Q4	–	Sell	-34,785	Closed	-$1.4M	–	746
2016 Q3	$1.4M	Buy	34,785 +4,560	+15%	+$172K	0.04%	371
2016 Q2	$1M	Sell	30,225 -24,735	-45%	-$846K	0.03%	394
2016 Q1	$1.62M	Sell	54,960 -187,620	-77%	-$5.18M	0.05%	288
2015 Q4	$6.39M	Sell	242,580 -6,750	-3%	-$175K	0.17%	141
2015 Q3	$5.91M	Sell	249,330 -807,270	-76%	-$19.5M	0.17%	136
2015 Q2	$25.1M	Buy	1,056,600 +59,580	+6%	+$1.34M	0.68%	45
2015 Q1	$23.7M	Buy	997,020 +17,880	+2%	+$401K	0.63%	55
2014 Q4	$20.8M	Buy	979,140 +628,350	+179%	+$12.6M	0.56%	59
2014 Q3	$5.97M	Buy	+350,790	New	+$5.54M	0.16%	138

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Chicago Equity Partners's EW Position: Q1 2020 in Review

Chicago Equity Partners increased its Edwards Lifesciences (EW) stake by 49% in Q1 2020, buying an estimated $288K and bringing the position to 12,075 shares worth $759K. The position accounts for 0.08% of the portfolio, ranked #329.

Chicago Equity Partners first reported a position in EW in Q3 2014 and has held it in 13 quarters since. The position peaked at $25.1M in Q2 2015. 1,019 funds tracked by Wall St. Rank hold EW as of Q1 2020.

Chicago Equity Partners held 12,075 shares of Edwards Lifesciences worth $759K as of Q1 2020.
Chicago Equity Partners bought 3,990 Edwards Lifesciences shares in Q1 2020, an estimated $288K.
Edwards Lifesciences made up 0.08% of Chicago Equity Partners's portfolio in Q1 2020, its #329 holding.
Chicago Equity Partners first reported a position in Edwards Lifesciences in Q3 2014 and has held it in 13 quarters since.
Chicago Equity Partners's Edwards Lifesciences position peaked at $25.1M in Q2 2015.
1,019 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.